back to the list

Rhabdomyolysis and exercise intolerance - MTCYB, CPT2, ETFDH, LPIN1

Clinical Features

Rhabdomyolysis is a common clinical syndrome that results from acute muscle fiber necrosis with leakage of muscle constituents into blood. Myoglobinuria is the most significant consequence, leading to acute renal failure (ARF) in 15% of patients with rhabdomyolysis. Rhabdomyolysis occurs from inherited diseases, toxins, muscle compression, overexertion, or inflammatory processes, among other disorders. In some cases, no cause is found.

Genetic Information

Many of the reported cases of familial myoglobinuria are related to carnitine palmitoyltransferase deficiency, caused by mutations in the CPT2 gene. Myoglobinuria also occurs with deficiency of muscle phosphorylase (McArdle disease), caused by mutations in the gene encoding muscle glycogen phosphorylase (PYGM). Mitochondrial deficiency might also lead to rhabdomyolysis. Most frequently, mutations in the mtDNA Cytb gene were identified, however patients were reported carrying mutations in mtDNA COI-III, ND and tRNA genes.

Prevalence

Rhabdomyolysis itself is relatively frequent, however the exact prevalence of the disease with mitochondrial origin is not known.

 

Diagnostic

 

Indication

Rhabdomyolysis with exercise intolerance and high CK (often high lactate) with ragged red fibers

Method

Mutation analysis for mtDNA Cytb, tRNA, COI-III or ND mutations by DNA sequencing (depending on the activities of the respiratory chain enzymes in muscle)

Sample Requirement

Muscle DNA (for tRNA mutations EDTA-blood)

Duration

2 - 5 weeks



back to the list